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Received February 20, 2012; accepted August 10, 2012AbstractBackground: Continuouspassivemotion after amajor knee surgery optimizes functional prognosis, but causes severe pain. In this study,we assessed the
effect of intravenous patient-controlled analgesia (IVPCA) on postoperative pain management in unilateral and bilateral total knee arthroplasty (TKA).
Methods: Data were collected retrospectively from a single medical center from March 2003 to October 2007. All patients who had undergone TKA
were given general anesthesia, and the type of surgery that each patient received was planned according to individual needs. A total of 223 patients
qualified for this study, with 174 patients in the unilateral TKA group. Data on patient demography, pain scores, and side effect scores were collected.
Total dose consumption, demand, delivery doses, demand-to-delivery ratio, and infusion rate were collected from PCA machines and analyzed.
Results: The patient pain score and patient satisfaction showed no significant difference between the unilateral and bilateral TKA groups. The
incidence of sedation ( p < 0.001), nausea ( p ¼ 0.013), and vomiting ( p ¼ 0.044) during the postoperative 24e48-hour period was higher in the
bilateral TKA group. Compared with the patients in the unilateral group, those in the bilateral group showed significantly greater dose consumption
during the postoperative 6e12-, 12e18-, and 18e24-hour periods. They also showedmore demand formedication during the postoperative 12e18-
and 18e24-hour periods and received more bolus doses during the postoperative 12e18-, 18e24-, and 30e36-hour periods. In addition, there was
also a significantly higher demand-to-delivery ratio for patients in the bilateral group during the postoperative 6e12-, 12e18-hour periods.
Conclusion: In this study, we successfully demonstrated that our IVPCA protocol can provide adequate analgesia for patients after both bilateral
and unilateral TKA. However, sedation, nausea, and vomiting occurred more frequently during the postoperative 24e48-hour period in patients
who underwent bilateral than unilateral TKA. This may due of the increased number of bolus doses administered to the patients in the bilateral
TKA group during the postoperative 12e18, 18e24, and 30e36-hour periods. Therefore, the initial infusion rates for patients undergoing
bilateral TKA could be set at a lower threshold in order to reduce the incidence of these side effects.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Total knee arthroplasty (TKA) can be performed in a one-
stage, simultaneous bilateral knee procedure or a two-stage,
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http://dx.doi.org/10.1016/j.jcma.2013.02.005patient’s ability to perform postoperative knee rehabilitation,
and thus affects the TKA outcome.3 For patients who un-
dergo bilateral knee surgery, concerns regarding post-
operative recovery and pain management have been the
subject of considerable debate.4e6 By contrast, postoperative
pain relief can be achieved through a variety of techniques.
Among them, patient-controlled analgesia (PCA) is fre-
quently used in the postoperative stage of TKA, although
widely varied clinical efficacies of this technique have been
















Age 73.43 8.413 67.11 10.093 0.003*
Height (cm) 155.54 9.413 152.09 25.479 0.296
Weight (kg) 66.73 12.061 69.14 10.351 0.415
Gender (female) 65 63.1 13 68.4 0.659
*p < 0.05.
SD ¼ standard deviation.
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they have a contraindication for regional anesthetics, although
epidural anesthesia provides improved pain relief, faster knee
rehabilitation, and fewer side effects than IVPCAwithmorphine.7
Shetty et al and Singelyn et al indicated that pain scores, total
opioid consumption, and side effects were similar for patients
receiving IVPCAwith unilateral and bilateral TKA.3,8 However,
to the best of our knowledge, there has been no reported study
comparing the patientemachine interactions by demandedeliv-
ery patterns that are automatically recorded by PCA machines,
focusing on patients with unilateral and bilateral TKA.
The purpose of this study was to determine whether pa-
tients who underwent bilateral TKA respond differently to a
standardized IVPCA protocol compared with those who un-
derwent unilateral TKA. Side effects such as sedation, sensory
blockade, motor blockade, nausea, and vomiting were also
compared. The patientemachine interaction was analyzed for
demandedelivery patterns.
2. Methods
This study was conducted at the Taipei Veterans General
Hospital, and ethical approval was obtained from its Institu-
tional Review Board (VGHIRB No. 2011-03-037IC). A total
of 245 patients who underwent TKA and IVPCA were iden-
tified from the PCA database between March 2003 and
October 2007. All patients had been surgically classified as
American Society of Anesthesiologists Class I or II. Those
who had the following conditions were excluded: early
termination of the IVPCA program due to drug allergies
(n ¼ 3); technical problems such as catheter disconnection
(n ¼ 2); receiving additional intravenous or oral analgesics
during the IVPCA program (n ¼ 10); or associated with severe
postoperative complications such as infection, bleeding, and
cardiovascular or pulmonary events (n ¼ 7). A total of 223
(91%) patients were selected for the final analysis. Data on
age, height, weight, and gender were collected as patient’s
demographic data. Our IVPCA regimen consisted of droper-
idol (5 mg) and morphine (1 mg/mL) in 0.9% normal saline
(100 mL) and was administered through an Abbott Aim Plus
PCA machine (Abbott Laboratories, Abbott Park, IL, USA).
The pain pump was programmed to deliver a continuous dose
of medications and was connected to the patients immediately
after their arrival in the postoperative recovery room. Initially,
the machine was programmed to deliver a continuous dose of
0.015 mL/kg/hour and a bolus dose of 0.02 mL/kg/hour, which
were then adjusted by PCA nurses to maintain patient satis-
faction and pain level. There was a 4-hour upper limit with a
range of 6e12 mg for total dosage according to patient age
and medical comorbidities. The regimens were given to pa-
tients through a PCA machine programmed to deliver a
continuous dose of medications and to deliver a bolus dosage
as requested by the patient. However, as a precautionary
measure, the bolus dose delivery was limited to 5e10-minute
intervals regardless of the patient’s demand. The drug con-
sumption was recorded in units of milliliters administered over
a 6-hour period. The demand for PCA medications wasrecorded as the number of times the patient requested medi-
cation. The delivery of PCA medications was recorded as the
number of boluses of drug delivered in a 6-hour period.
Postoperative pain scores during rest and movement were
assessed by patients using a visual analog scale (VAS) (0 ¼ no
pain, 1 ¼ a little pain, and 10 ¼ extreme pain) in the 24-hour
postoperative period, and recorded by independent PCA nurses.
The pain relief scale (0¼ no relief and 4 ¼ total relief) was also
assessed by independent PCA nurses. Postoperative side effects
such as nausea, dizziness, vomiting, and itching were evaluated
on a scale of 0e3 (0¼ no side effect and 3 ¼ severe side effect)
and were determined using a questionnaire by independent PCA
nurses. Moreover, sedation effects (0 ¼ good awareness,
1 ¼ arousable sedation, 2 ¼ arousable to pain, and 4 ¼ coma)
were also evaluated. Thedata on total dose consumption, demand,
anddelivery doseswere downloaded fromthePCAmachines, and
the demand-to-delivery ratio was analyzed.2.1. Statistical analysisParametrical data are presented as mean with standard de-
viation, and categorical data are expressed as count with
percentage. Independent t test or Chi-square test was used to
compare patient characteristics and variables related to IVPCA
usage between the two groups. Any p value <0.05 was
considered statistically significant. All statistical analyses
were performed using SPSS version 17.0 for Windows (SPSS
Inc., Chicago, IL, USA).
3. Results
A total of 223 patients qualified for this study and their de-
mographic data including age, weight, height, and gender were
collected (Table 1). The bilateral TKA group consisted of 16
men and 33 women, with a mean age of 67.11 years, whereas
the unilateral TKA group consisted of 68 men and 106 women,
with a mean age of 73.43 years. Patients undergoing unilateral
TKA were significantly older ( p ¼ 0.003). The height, weight,
and gender (female) of patients in each group were compatible.
We obtained VAS scores at rest and during movement, as
well as pain relief scores from all study participants (Table 2).
There were no significant differences in pain scores between
the two groups. The patients reported side effects such as
nausea, dizziness, itching (Table 3). There were significantly
Table 2






Rest (0e24) 1.46  1.45 1.16  1.34 0.406
Rest (24e48) 0.88  0.93 0.89  0.93 0.962
Move (0e24) 1.78  2.02 2.00  2.31 0.666
Move (24e48) 3.18  1.47 2.79  1.32 0.276
PRS (0e24) 1.93  1.37 1.84  1.26 0.791
PRS (24e48) 2.78  0.96 3.00  0.47 0.126
Data are expressed as mean  standard deviation.
PRS ¼ pain relief scale.
a Scale of 0e10: 0 ¼ no pain, 10 ¼ worst pain.
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24e48-hour period in the bilateral group than in the unilateral
group. There were also a significantly higher number of
nausea ( p ¼ 0.013) and vomiting ( p ¼ 0.044) episodes during
the postoperative 24e48-hour period in the bilateral group
than in the unilateral group.
The use of IV drugs was analyzed in 6-hour intervals
(Fig. 1). There was significantly more consumption of drugs
among the patients in the bilateral TKA group during the
postoperative 6e12-, 12e18-, and 18e24-hour periods than
by the patients in the unilateral TKA group. In addition, there
was significantly more demand for medication from patients in
the bilateral TKA group during the postoperative 12e18- and
18e24-hour periods than by the patients in the unilateral TKA
group. The delivery of bolus doses was also significantly
greater in the bilateral TKA patients during the postoperative
12e18-, 18e24-, and 30e36-hour periods. During the post-
operative 0e6-, 24e30-, 36e42-, and 42e48-hour periods,
there were no significant differences between the two groups
with regard to drug consumption, demand, and delivery.
However, there was significantly more demand-to-delivery
ratio for patients in the bilateral group during the post-
operative 6e12-, 12e18-hour periods. The initial infusion rate
in the bilateral TKA group was significantly higher than that in
the unilateral TKA group (Fig. 2). However, during the post-
operative 0e48-hour periods, there was no significant differ-
ence in the infusion rate between both groups.Table 3






Count % Count %
Sed (0e24) 2 20.4 5 26.3 0.564
Sed (24e48) 18 17.5 11 57.9 <0.001*
Nausea (0e24) 11 10.7 1 5.3 0.468
Nausea (24e48) 5 4.9 4 21.1 0.013*
Dizziness (0e24) 22 21.4 3 15.8 0.582
Dizziness (24e48) 21 20.4 3 15.8 0.716
Vomiting (0e24) 6 5.8 2 10.5 0.449
Vomiting (24e48) 4 3.9 3 15.8 0.044*
Itching (0e24) 6 5.8 2 10.5 0.449
Itching (24e48) 21 20.4 4 21.1 0.948
*p <0.05.
a 0 ¼ no side effect, 1 ¼ mild, 2 ¼ moderate, 3 ¼ severe (side effect ¼ 1 or
2 or 3).4. Discussion
Postoperative pain after TKA is a major concern, and is the
most influential factor for satisfactory postoperative knee
rehabilitation.3,9 Results of several studies have shown that
management of this pain with regional analgesia has reduced
complications and improved outcomes.8,10,11 However,
regional analgesia is not suitable for all patients. Therefore,
IVPCA has been used as an alternative method to manage pain
in patients who underwent TKA.
PCA provides better relief from pain and anxiety, as well as
better patient satisfaction than nurse-controlled analgesia,12
thereby facilitating better recovery.13 In the PCA setting,
interaction between the patients and PCA machine is deter-
mined by the number of demands and bolus drug delivery. The
number of demands reflects the patient’s need for pain medi-
cations as well as their anxiety level.14 In this study, the pa-
tients were blinded to delivery limitations. Therefore, the
number of demands made by patients truly reflects the pa-
tients’ need for pain management. The number of successful
deliveries correlates with the degree of pain.15 The demand-to-
delivery ratio reflects the average number of times the button
is pressed in order to deliver an actual bolus dosage. It reflects
the anxiety level of pain and also the skill of the patient to
request analgesic bolus doses.16 To our knowledge, few pre-
vious studies on IVPCA discussed about patientemachine
interactions. Our study demonstrated similar pain scoring in
both TKA groups throughout the hospital stay, which is
similar to the result of the studies conducted by Shetty et al
and Powell et al on postoperative pain and rehabilitation using
intravenous pain control, in which no difference between the
two groups was found.8,17 However, in the postoperative
12e18 and 18e24-hour periods, we observed an increased
demand and delivery of medications in the bilateral group.
Increased demand-to-delivery ratio was also noted for patients
in the bilateral group during the postoperative 6e12- and
12e18-hour periods. This may be due to increasing anxiety
and anticipation of pain. This result was similar to those found
by Powell et al, in which they showed that pain was signifi-
cantly different only on postoperative Day 1.17
Evaluation of pain control efficacy and efficiency is important
in determining patient satisfaction. The VAS and pain relief
scoring arewidely used to objectify the severity of pain. However,
VAS is affected by the timing of drug administration to data
collection and the patient’s perception of their state of health.
Therefore, we analyzed the interaction between the patient and
the PCA machine so that more objective information could be
collected. By contrast, patient pain relief scale was evaluated by
observation of changes in activities of daily life, and primarily
when the patient is in a state of rest. The mean VAS at rest in the
patients with unilateral and bilateral knee surgery in the post-
operative 24e48-hour period was 0.88  0.93 and 0.89  0.93,
respectively (Table 2). The VAS values were low and the pain
relief scale in the postoperative 24e48-hour period is 2.78 0.96
(unilateral) and 3.00 0.47 (bilateral), which denoted good pain
management. Most patients receive additional rehabilitation in
the postoperative 24e48-hour period, which is the reason why
Fig. 1. Comparison of dosing data with regard to total drug consumption, demand, delivery, and demand-to-delivery ratio between the unilateral and bilateral total
knee arthroplasty (TKA) groups (*p < 0.05, **p < 0.01).
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(unilateral) in the postoperative 0e24-hour period.
Compared with the report by Singelyn et al concerning
postoperative pain after unilateral TKA using IVPCA,18 the
current study demonstrated less total consumption of
morphine during the first 48 postoperative hours, with lowerFig. 2. Comparison between unilateral total knee arthroplasty (TKA) and
bilateral TKA with regard to the infusion rates (*p < 0.05).VAS and fewer side effects such as nausea and vomiting. By
contrast, the maximum dosage (6e12 mg/4 hours) used in this
study is lower than that dosage noted in the report by Cap-
devila et al (30 mg/4 hours).11 The precise explanation for this
is not clear, though possible reasons are differences in in-
strument, surgeon, race, and patient age.
Powell et al reported that, compared with unilateral TKA,
simultaneous bilateral TKA may lead to increased pain during
the first 2 days, and lagging ambulatory milestones at 36
hours.17 In this study, we observed a pattern of increased drug
consumption in all patients in the bilateral TKA group, except
during the postoperative 36e42-hour period, as well as a
significantly higher initial infusion rate among the patients in
the bilateral TKA group. This may be due to the fact that the
pain scores for bilateral patients were 1 point higher on day
1.17 Because drug consumption increased in the bilateral TKA
group, there was no significant difference in pain scores be-
tween the two groups. Patients who underwent unilateral TKA
were older than those of the bilateral TKA group. It was not
clear whether older age was associated with lower drug con-
sumption or poorer outcome. During the postoperative 0e6-
hour period, there was no significant difference between the
two groups in terms of drug consumption, demand, delivery,
and demand-to-delivery ratio, which may be due to residual
anesthesia in the patients.
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taneous bilateral total knee arthroplasty (SBTKA) patients
from studies such as this one, the safety of simultaneous
bilateral TKA remains controversial. Restrepo et al compared
staged bilateral and unilateral total knee replacement, and
found that simultaneous total knee replacement carries a
higher risk of serious cardiac complication, pulmonary
complication, and mortality.20 A staged operation appears to
be safer than simultaneous bilateral total knee replacement for
patients who are 75 years or older.2 This may be the reason
that the patients who underwent unilateral TKA in the present
study are older than those in the bilateral TKA group.
One of the limitations of this study was that it was a
retrospective study. Data were not collected prospectively;
therefore, the control groups were not randomly selected.
Although a close matching of the two groups was attempted,
the patients in the unilateral group were older. In addition,
underlying diseases in the patients were not recorded. There-
fore, the progression of disease and whether the patient was a
candidate undergoing two-staged bilateral TKA or simple
unilateral TKA was not known. This difference may influence
the quality of life, pain score, and drug consumption.
In conclusion, this study supports IVPCA as an effective
modality for both unilateral and bilateral arthroplasty. How-
ever, the patients in the bilateral TKA group suffered more
from sedation, nausea, and vomiting side effects during the
postoperative 24e48-hour period. This may be related to
increased delivery of bolus doses during the postoperative
12e18-, 18e24-, and 30e36-hour periods. The initial infusion
rate could therefore be set at a lower level for patients with
bilateral TKA, in order to reduce the side effects of morphine.
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